The National Board of Revenue (NBR) issued an SRO on 22nd March 2020 that has waived the import duty restrictions, regulatory taxes, supplementary taxes, VAT, advance tax and advance income taxes on medical items (17 HS Code in particular) required for the protection from the coronavirus, which can be availed with the prior approval of the Directorate General Drug Administration (DGDA).